Advancing Priority Research on the Middle East Respiratory Syndrome Coronavirus
- 11 November 2013
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 209 (2), 173-176
- https://doi.org/10.1093/infdis/jit591
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Middle East Respiratory Syndrome Coronavirus in Bats, Saudi ArabiaEmerging Infectious Diseases, 2013
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapyInternational Journal of Infectious Diseases, 2013
- Middle East Respiratory Syndrome Coronavirus Infections in Health Care WorkersNew England Journal of Medicine, 2013
- Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptomsClinical Microbiology & Infection, 2013
- Suppression of Coronavirus Replication by Cyclophilin InhibitorsViruses, 2013
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing AntibodiesJournal of Virology, 2013
- Identification and Characterization of a Novel Alpaca Respiratory Coronavirus Most Closely Related to the Human Coronavirus 229EViruses, 2012
- Cyclosporin A inhibits the replication of diverse coronavirusesJournal of General Virology, 2011
- Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesProceedings of the National Academy of Sciences of the United States of America, 2009
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004